About us

Huabo Biopharm Co., Ltd., (aka ‘Huabo Biopharm’), established in June 2011, is a subsidiary of Shanghai Huaota Pharmaceutical Co., Ltd. At Huabo Biopharm, the R&D team is led by two distinguished experts...

Huabo focuses on the research and development of new biological drugs in the fields of tumor...

NEWS

13
2023-10
Huaota will present promising result of HB0034 at the 32nd EADV
The much-anticipated 32nd EUROPEAN ACADEM...
Learn more+
01
2021-04
The First Subject Has Been Administrated Successfully with Huaota Anti-CD137 mAb For Phase I Clinical Trial in China
Today, a patient of Shanghai Chest Hospit...
Learn more+
01
2021-04
Exclusive Interview | Huaota CEO Dr. Zhu Xiangyang:
Entering the 21st century, tumor immunoth...
Learn more+
21
2021-01
HB0025 Injection Obtained NMPA IND Approval for Phase I Clinical Trial
HB0025 Injection Obtained NMPA IND Approv...
Learn more+

Product pipeline

TALENT
RECRUITMENT

Contact us

Consultation hotline:

+86-021-50799120
  • Tel

    +86-021-50799120

  • E-mail

    hr@huabobio.com

  • Address

    1800 Cailun Road, Zhangjiang High Tech Park, Pudong New District, Shanghai